Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb trial of Yishen Huazhuo granules in low-risk idiopathic membranous nephropathy
ChiCTR2300070304Phase 2Recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Mar 2023
- Countries
- 1
01
Overview
Phase 2, randomised trial of Yishen Huazhuo Granules in idiopathic membranous glomerulonephritis (IMG) (3 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Change in 24-hour urine protein quantification from baseline, Change in serum albumin from baseline and 5 more. Started Mar 2023; status: recruiting.
02
Drugs
Yishen Huazhuo Granules
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on ChiCTR2300070304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070304.